First AD

Second AD

Experts on AYA ALL discuss the potential applicability of modified treatment regimens and the importance of multidisciplinary collaboration to meet the unique needs of patients.

The Potential of Modified Treatment Regimens in AYA ALL

Video content above is prompted by the following:

Discuss the potential applicability of modified treatment regimens, such as the modified version of 10403.

How can the multidisciplinary healthcare team, including physicians, nurses, pharmacists, and social workers, collaborate effectively to meet the unique needs of patients with AYA ALL?

Hematologic Oncology

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

Inside the Clinic: Treating AYA ALL